Maze Therapeutics Inc. (MAZE)
NASDAQ · Healthcare
Maze Therapeutics Inc. Operating Income 2024–2024
Maze Therapeutics Inc. annual/quarterly operating income history and growth rate from 2024 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Maze Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -26.6 M.
- Maze Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was 52.3 M.
- Maze Therapeutics Inc. annual operating income for 2024 was 57.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Maze Therapeutics Inc. Operating Income — FAQ
Maze Therapeutics Inc. (MAZE) operating income over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
What is Maze Therapeutics Inc.'s operating income?
Maze Therapeutics Inc. (MAZE) reported operating income of $58M for fiscal 2024.
Where can I see MAZE's operating income history?
The chart and table above show Maze Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.